Back to top

Is CHRS primed for upward momentum? MACD Bullish Signal Line Cross shows up after gaining 4.26%

Coherus BioSciences, Inc. (CHRS) — Nightly Technical Analysis · Jul 30, 2026, 17:39 ET
CHRS closed up 4.26% on Thursday, July 30th, with volume running 0.6× below average. Mixed technical signals appeared with MACD Bullish Signal Line Cross suggesting upside potential, while 20 DMA Resistance indicated possible weakness — creating a conflicted technical picture. Key support levels exist at 1.43, 1.39 & 1.36, with resistance at 1.5, 1.52 & 1.57.

Current SwingTradeBot Technical Rating of CHRS: D

Just a sneak peek — check SwingTradeBot.com for the full story on CHRS.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coherus Oncology, Inc. (CHRS)